We are a biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. 

We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with Ewing's sarcoma.

See how we can help

Contact us